1366 related articles for article (PubMed ID: 33560862)
1. Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Abraham GM; Jokela JA; Forciea MA; Miller MC; Humphrey LL; ; Centor RM; Andrews R; Haeme R
Ann Intern Med; 2021 May; 174(5):673-679. PubMed ID: 33560862
[TBL] [Abstract][Full Text] [Related]
2. Remdesivir for Adults With COVID-19 : A Living Systematic Review for American College of Physicians Practice Points.
Wilt TJ; Kaka AS; MacDonald R; Greer N; Obley A; Duan-Porter W
Ann Intern Med; 2021 Feb; 174(2):209-220. PubMed ID: 33017170
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients.
Wu TY; Chen PY; Wang JT; Liu WD; Chen YC; Chang SC
J Antimicrob Chemother; 2024 May; 79(5):1196-1200. PubMed ID: 38538154
[No Abstract] [Full Text] [Related]
4. SARS-CoV-2 Antiviral Prescribing Gaps Among Nonhospitalized High-Risk Adults.
Levy ME; Burrows E; Chilunda V; Pawloski PA; Heaton PR; Grzymski J; Goldman JD; McEwen LM; Wyman D; Dei Rossi A; Dai H; Isaksson M; Washington NL; Basler T; Tsan K; Nguyen J; Ramirez J; Sandoval E; Lee W; Lu J; Luo S
Clin Infect Dis; 2024 Jun; 78(6):1531-1535. PubMed ID: 38170452
[TBL] [Abstract][Full Text] [Related]
5. Remdesivir-based therapy improved the recovery of patients with COVID-19 in the multicenter, real-world SARSTer study.
Flisiak R; Zarębska-Michaluk D; Berkan-Kawińska A; Tudrujek-Zdunek M; Rogalska M; Piekarska A; Kozielewicz D; Kłos K; Rorat M; Bolewska B; Szymanek-Pasternak A; Mazur W; Lorenc B; Podlasin R; Sikorska K; Oczko-Grzesik B; Iwaszkiewicz C; Szetela B; Pabjan P; Pawłowska M; Tomasiewicz K; Polańska J; Jaroszewicz J
Pol Arch Intern Med; 2021 Jan; 131(1):103-110. PubMed ID: 33382547
[No Abstract] [Full Text] [Related]
6. Remdesivir for COVID-19: Why Not Dose Higher?
Yan VC; Muller FL
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558301
[No Abstract] [Full Text] [Related]
7. Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.
Buckland MS; Galloway JB; Fhogartaigh CN; Meredith L; Provine NM; Bloor S; Ogbe A; Zelek WM; Smielewska A; Yakovleva A; Mann T; Bergamaschi L; Turner L; Mescia F; Toonen EJM; Hackstein CP; Akther HD; Vieira VA; Ceron-Gutierrez L; Periselneris J; Kiani-Alikhan S; Grigoriadou S; Vaghela D; Lear SE; Török ME; Hamilton WL; Stockton J; Quick J; Nelson P; Hunter M; Coulter TI; Devlin L; ; ; Bradley JR; Smith KGC; Ouwehand WH; Estcourt L; Harvala H; Roberts DJ; Wilkinson IB; Screaton N; Loman N; Doffinger R; Lyons PA; Morgan BP; Goodfellow IG; Klenerman P; Lehner PJ; Matheson NJ; Thaventhiran JED
Nat Commun; 2020 Dec; 11(1):6385. PubMed ID: 33318491
[TBL] [Abstract][Full Text] [Related]
8. Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response.
Goyal A; Cardozo-Ojeda EF; Schiffer JT
Sci Adv; 2020 Nov; 6(47):. PubMed ID: 33097472
[TBL] [Abstract][Full Text] [Related]
9. Dynamic diversity of SARS-CoV-2 genetic mutations in a lung transplantation patient with persistent COVID-19.
Igari H; Sakao S; Ishige T; Saito K; Murata S; Yahaba M; Taniguchi T; Suganami A; Matsushita K; Tamura Y; Suzuki T; Ido E
Nat Commun; 2024 Apr; 15(1):3604. PubMed ID: 38684722
[TBL] [Abstract][Full Text] [Related]
10. Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.
Béraud G; Timsit JF; Leleu H
PLoS One; 2022; 17(1):e0262462. PubMed ID: 35020746
[TBL] [Abstract][Full Text] [Related]
11. Renal and Hepatic Toxicity Analysis of Remdesivir Formulations: Does What Is on the Inside Really Count?
Shah S; Ackley TW; Topal JE
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0104521. PubMed ID: 34310212
[TBL] [Abstract][Full Text] [Related]
12. Challenges in Treating Pediatric Cancer Patients during the COVID-19 Pandemic: Balancing Risks and Care.
Chávez-Pacheco JL; Castillejos-López M; Hernández-Regino LM; Velasco-Hidalgo L; Zapata-Tarres M; Correa-Carranza V; Rosario-Méndez G; Barrientos-Ríos R; Aquino-Gálvez A; Torres-Espíndola LM
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793571
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Drug Treatments Are Prone to Sequestration in Extracorporeal Membrane Oxygenation Circuits: An Ex Vivo Extracorporeal Membrane Oxygenation Study.
Dhanani JA; Shekar K; Parmar D; Lipman J; Bristow D; Wallis SC; Won H; Sumi CD; Abdul-Aziz MH; Roberts JA
ASAIO J; 2024 Jun; 70(6):546-552. PubMed ID: 38829573
[TBL] [Abstract][Full Text] [Related]
14. Response to Comments on "Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites".
Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2022 Feb; 101(2):121-122. PubMed ID: 35105679
[No Abstract] [Full Text] [Related]
15. Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry.
Schimmel J; Epperson LC; Aldy K; Wax P; Brent J; Buchanan J; Levine M; Burkhart K;
Drugs; 2024 Feb; 84(2):209-217. PubMed ID: 38198063
[TBL] [Abstract][Full Text] [Related]
16. Response to Özdemir Ö on "Kounis syndrome due to remdesivir allergy".
Beneki E; Dimitriadis K; Antonopoulos A; Aggeli K; Tsioufis K
Clin Toxicol (Phila); 2024 Apr; 62(4):275-276. PubMed ID: 38639134
[No Abstract] [Full Text] [Related]
17. COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE).
Rouger-Gaudichon J; Bertrand Y; Boissel N; Brethon B; Ducassou S; Gandemer V; Halfon-Domenech C; Leblanc T; Leverger G; Michel G; Petit A; Ray-Lunven AF; Rohrlich PS; Schneider P; Sirvent N; Strullu M; Baruchel A;
Bull Cancer; 2021 May; 108(5):490-500. PubMed ID: 33781551
[TBL] [Abstract][Full Text] [Related]
18. Comment on Beneki E, Dimitriadis K, Antonopoulos A, Aggeli K & Tsioufis K. Kounis syndrome due to remdesivir allergy.
Özdemir Ö
Clin Toxicol (Phila); 2024 Apr; 62(4):274-275. PubMed ID: 38655636
[No Abstract] [Full Text] [Related]
19. Remdesivir for the treatment of COVID-19: a Cochrane review.
Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
Emergencias; 2023 Dec; 35(6):465-467. PubMed ID: 38116972
[No Abstract] [Full Text] [Related]
20. An updated meta-analysis of pooled incidence of remdesivir-associated bradycardia.
Hung KC; Wang WT; Hung IY; Chen IW
J Med Virol; 2024 Apr; 96(4):e29584. PubMed ID: 38563309
[No Abstract] [Full Text] [Related]
[Next] [New Search]
